Invent targeted small molecule drugs
that are either first-in-class or second-generation
Selectively develop our drugs
to maximize their overall value
Perform a partnering strategy
in which we retain profit rights for drugs
through partner select early-stage programs
BiSiChem is a leading biotech company that focused on the discovery and
development of innovative therapeutic drugs on immuno-oncology,
targeted therapy and neuro-degenerative diseases.
Our goals are Good lives, Better innovation and Best therapy.
Our main focus is
“BiSiChem is a precision medicine company
developing a specific targeted therapy to treat cancer.”